280 related articles for article (PubMed ID: 27565917)
1. Quality of life, symptom status and physical performance in patients with advanced non-small cell lung cancer undergoing chemotherapy: an exploratory analysis of secondary data.
Shallwani SM; Simmonds MJ; Kasymjanova G; Spahija J
Lung Cancer; 2016 Sep; 99():69-75. PubMed ID: 27565917
[TBL] [Abstract][Full Text] [Related]
2. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
3. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
[TBL] [Abstract][Full Text] [Related]
4. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
[TBL] [Abstract][Full Text] [Related]
5. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
[TBL] [Abstract][Full Text] [Related]
6. Symptom experiences and health-related quality of life among non-small cell lung cancer patients participating in clinical trials.
Lee K; Oh EG; Kim S; Kim SW
J Clin Nurs; 2019 Jun; 28(11-12):2111-2123. PubMed ID: 30667122
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
[TBL] [Abstract][Full Text] [Related]
8. Assessment of quality of life in patients with advanced non-small cell lung carcinoma treated with a combination of carboplatin and paclitaxel.
Avelino CU; Cardoso RM; Aguiar SS; Silva MJ
J Bras Pneumol; 2015; 41(2):133-42. PubMed ID: 25972967
[TBL] [Abstract][Full Text] [Related]
9. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
[TBL] [Abstract][Full Text] [Related]
10. Symptom Assessment for Patients with Non-small Cell Lung Cancer Scheduled for Chemotherapy.
Silvoniemi M; Vasankari T; Löyttyniemi E; Valtonen M; Salminen E
Anticancer Res; 2016 Aug; 36(8):4123-8. PubMed ID: 27466520
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L
Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373
[TBL] [Abstract][Full Text] [Related]
12. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
Iyer S; Taylor-Stokes G; Roughley A
Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
Lal R; Hillerdal GN; Shah RN; Crosse B; Thompson J; Nicolson M; Vikström A; Potter VA; Visseren-Grul C; Lorenzo M; D'yachkova Y; Bourayou N; Summers YJ
Lung Cancer; 2015 Aug; 89(2):154-60. PubMed ID: 26101013
[TBL] [Abstract][Full Text] [Related]
14. Deterioration in physical activity and function differs according to treatment type in non-small cell lung cancer - future directions for physiotherapy management.
Granger CL; Parry SM; Edbrooke L; Denehy L
Physiotherapy; 2016 Sep; 102(3):256-63. PubMed ID: 26597694
[TBL] [Abstract][Full Text] [Related]
15. The Impact of a Multidimensional Exercise Intervention on Physical and Functional Capacity, Anxiety, and Depression in Patients With Advanced-Stage Lung Cancer Undergoing Chemotherapy.
Quist M; Adamsen L; Rørth M; Laursen JH; Christensen KB; Langer SW
Integr Cancer Ther; 2015 Jul; 14(4):341-9. PubMed ID: 25800229
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089).
Rittmeyer A; Gorbunova V; Vikström A; Scherpereel A; Kim JH; Ahn MJ; Chella A; Chouaid C; Campbell AK; Barlesi F
J Thorac Oncol; 2013 Nov; 8(11):1409-16. PubMed ID: 24077452
[TBL] [Abstract][Full Text] [Related]
17. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
[TBL] [Abstract][Full Text] [Related]
18. Assessing functional status and the survival benefit of chemotherapy for advanced non-small cell lung cancer using administrative claims data.
Feliciano J; Gardner L; Hendrick F; Edelman MJ; Davidoff A
Lung Cancer; 2015 Jan; 87(1):59-64. PubMed ID: 25443272
[TBL] [Abstract][Full Text] [Related]
19. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in lung cancer patients in Serbia: correlation with socio-economic and clinical parameters.
Maric D; Jovanovic D; Golubicic I; Dimic S; Pekmezovic T
Eur J Cancer Care (Engl); 2010 Sep; 19(5):594-602. PubMed ID: 20030692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
